Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review

Hudson Robotics announces new easy-to-use interfaces for complex instruments

Hudson Robotics announced the release of multiple new interfaces for SoftLinx™ V software that allows users to easily integrate complex instruments. Laboratories can now quickly, easily and affordably automate complex readers, incubators, Real-Time PCR instruments and liquid handling systems.

Read more >>

Pharmaceutical & life science news:

Sanofi-aventis strengthens support for patient groups with launch of Patient Group Bursary
Sanofi-aventis has signalled a strengthening of its support for patient groups in the UK...

GSK publishes 2010 Corporate Responsibility Report
In its Corporate Responsibility Report, GSK reiterated its commitment to building its business on strong values...

AZ, Pfizer and GSK leaders endorse university’s Quality by Design course
De Montfort University’s unique QbD course received major endorsement by senior industry leaders when it was launched last week...

FDA Approves YERVOY™ (ipilimumab)
For the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer...

Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA
Yesterday Boehringer Ingelheim formally acquired Amgen’s biopharmaceutical development and manufacturing facility in Fremont, California (USA)...

GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
GSK announced that it will no longer pursue global approval for the use of Avodart™...

Sanofi-aventis strengthens commitment to ophthalmology through partnership with the Vision Institute
Sanofi-aventis announced the signing of a cooperation agreement between Fovea Pharmaceuticals & the Vision Institute...

Conferences, events & exhibitions:

NGP Europe Summit 2011
5 - 7 April 2011, Park Hotel Bremen
Such emphasis has been placed on helping Europe climb back to the top of the R&D ladder. The European pharmaceutical sector must currently focus on innovative solutions which can integrate seamlessly with existing technologies and strategies, which are key factors in bringing drugs to market quicker and more effectively. Given the multitude of new pharmaceuctical R&D institutes and the determination of the EU to revive Europe's status as an innovation leader in drug discovery, returns on such R&D investment over the next few years could potentially boom. Leaders in the R&D space know that now is the time to commit to drug discovery.

Analytical Method Validation for Biologics, Biopharmaceuticals and Other Therapeutic Products
4 - 5 April, Berlin, Germany

Pharmaceutical and Biopharmaceutical Quality Control Laboratories - A Regulatory Compliance Primer
4 - 5 April, Dublin, Ireland

MODA Global Seminar Series, Next Gen QC Micro
April 4: Paris, April 6: Frankfurt, April 7: London

QA/QC Strategy for Biologics and Biopharmaceuticals
6 - 8 April 2011 Berlin, Germany

RNAi & miRNA World Congress
26 - 27 April 2011 Boston, MA, USA

NEW! The Unscrambler Process Pulse - from CAMO Software

Real-time process monitoring solution at the heart of your process environment

Process quality is monitored and displayed in real-time

The Unscrambler Process Pulse lets you monitor your process in real-time and predict process deviations before they occur. The Unscrambler Process Pulse helps you:

  • Improve control of process quality
  • Implement real-time release
  • Reduce waste and downtime
  • Take the guess-work out of end-product quality

The solution is underpinned by the powerful diagnostic and predictive engine of CAMO Software's leading multivariate analysis software, allowing you to predict quality attributes for each batch before release to the next stage of manufacture.

Benefits of the Unscrambler Process Pulse

  • Scalable, easy to integrate and set up
  • Easy to use for process operators
  • Affordable and provides a fast return on investment

Key features of the Unscrambler Process Pulse

  • Import options customizable for user-specified formats
  • User-friendly dashboards for Process Operators
  • Set control limits or choose statistical test limits such as Hotelling T2
  • Wide range of graphic outputs with the ability to add more and configure to your requirements
  • Clear notification and alerts if batch quality is outside the control limits


Join European Pharmaceutical Review on LinkedIn


Follow European Pharmaceutical Review on Twitter